Skip to content

Effect of Snacks on Appetite Control

A Randomized, Controlled, Cross-over Study of the Effect of Snacks on Appetite Control

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01806688
Enrollment
46
Registered
2013-03-07
Start date
2013-07-06
Completion date
2014-08-23
Last updated
2021-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appetite Control, Healthy Canadians

Keywords

satiety, appetite, snack

Brief summary

This clinical trial is being conducted to study whether eating certain snacks will reduce your desire to eat and for a longer period of time compared to other snacks. The investigators are testing 2 different snacks. Study #1 will involve eating 2 different seed-like snacks or water. Study #2 will involve eating pita bread with jam, bread with jam or water. The test snack is higher in protein and/or fibre compared to the reference product.

Detailed description

Healthy adults will be recruited to participate in a randomized, controlled, crossover study to investigate whether or not eating snacks made with buckwheat would increase satiety and reduce their energy intake when compared to a comparable snack. Water was included as a non-caloric control. The study consisted of 3 visits and participants would receive a different treatment at each visit. Visits were scheduled at least 7 days apart. Visual analog scales will be used to assess appetite related sensations at 7 time points, fasting, 30 minutes after consuming the snack and then at 30 minute intervals for 180 minutes. Participants will be provided with a lunch and the amount of food consumed will be weighed. I addition, participants will be asked to maintain a food record for the remainder of the day.

Interventions

OTHERgluten-free high protein snack #1

buckwheat groats 30g serving

OTHERgluten-free snack with similar energy density but 1/2 the protein as snack #1

32g serving of corn nuts

OTHERnon-caloric control

water

OTHERgluten-free high protein and high fibre snack #2

buckwheat and pinto bean flour pita bread 50g serving

OTHERgluten-free snack with similar energy density, but less protein and fibre than snack #2

50g serving of rice bread

Sponsors

Manitoba Agri-Health Research Network
CollaboratorOTHER
St. Boniface Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Intervention model description

Randomized crossover

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index 18-30kg/m2 * males and non-pregnant or non-lactating females

Exclusion criteria

* Diagnosis of disease by a medical doctor that requires medical treatment during the study period. * Daily tobacco use. * Physical Activity Level \>1.8. * Eat meals at irregular or unusual times. * Food allergy, aversion or unwillingness to eat study foods. * Use of any prescription or non-prescription drug, herbal or nutritional supplement known to affect appetite. * Presence of a gastrointestinal disorder. * Score \>65% on any 1 of the 3 categories of the Three Factor Eating Questionnaire-R18.

Design outcomes

Primary

MeasureTime frameDescription
Total Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)VAS administered pre-snack and then every 30 minutes after the first bite up to 180 minutes for a total of 7 time points.Appetite assessment was measured using a VAS questionnaire administered pre-snack and every 30 minutes post snack up to 180 minutes, for a total of 7 time points. The questionnaire included 4 questions (1) How hungry are you? (2) How full are you? (3) How strong is your desire to eat? (4) How much do you think you want to eat right now? Each question was followed by a 10 cm line anchored at the left and right ends by the opposing statements not at all and extremely for questions 1 and 2, very weak and very strong for question 3, and nothing at all and a very large amount for question 4. Participants provided their response to each question by marking a perpendicular line on the 10-cm line to indicate their answer. Scores were determined by measuring the distance in centimeters from the left anchor to the perpendicular line drawn by the participant. VAS scores over time were graphed and AUC was calculated using the trapezoid method.

Secondary

MeasureTime frameDescription
Number of Calories Consumed Post-snack Until Bedtimetime between snack consumption and bedtime (12 hours)Participants were provided with a food diary to record the amount and type of each food and beverage consumed for the remainder of the day. Energy consumed at lunch and the remainder of the day were quantified from food consumed at lunch and the food diary using Food Processor Nutrient Analysis Software.

Other

MeasureTime frameDescription
Gastrointestinal Side Effects24hParticipants were asked if they noticed any gastrointestinal side effects after having eaten the study food and the results were recorded.
Likeability of Test and Reference Products Based on Sensory Scalesimmediately after eating test or reference productLikability of the study products was assessed using a 5-point hedonic scale (1 = dislike extremely; 2 = dislike very moderately; 3 = neither like or dislike; 4 = like moderately; 5 = like extremely) for appearance, aroma, flavour, taste, texture and overall liking.

Countries

Canada

Participant flow

Recruitment details

289 candidates were screened between June 2013 and August 2014. Of these 289 candidates, 50 met the criteria and were determined to be eligible. The first participant was enrolled on July 6, 2013 and the last participant enrolled August 9, 2014. 46 participants were enrolled in the overall study and 30 of these completed both the seed study and the pita study while 16 participated in only one of the studies. 38 participants were randomized to the seed study and 38 to the pita study.

Pre-assignment details

30 people completed both studies and 16 participated in only 1 study.

Participants by arm

ArmCount
Seed Study
One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #1 is a gluten-free high protein snack comprised of a 30g serving of buckwheat groats. The placebo comparator reference product is a gluten-free snack with similar energy density, but 1/2 the protein as snack #1, comprised of a 32g serving of corn nuts. The placebo comparator non-caloric control is water.
38
Pita Study
One of three interventions to be administered at each visit, an experimental snack, a placebo comparator reference product or a placebo comparator non-caloric control. The experimental snack #2 is a gluten-free high protein and high fibre snack comprised of a 50g serving of buckwheat and pinto bean flour pita bread. The placebo comparator reference product is a gluten-free snack with similar energy density, but less protein and fibre than snack #2, comprised of a 50g serving of rice bread. The placebo comparator non-caloric control is water.
38
Total76

Baseline characteristics

CharacteristicSeed StudyPita StudyTotal
Age, Categorical
Pita Study
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
Pita Study
>=65 years
0 Participants1 Participants1 Participants
Age, Categorical
Pita Study
Between 18 and 65 years
0 Participants37 Participants37 Participants
Age, Categorical
Seed Study
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
Seed Study
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Seed Study
Between 18 and 65 years
37 Participants0 Participants37 Participants
Age, Continuous
Pita Study
33.5 years33.5 years
Age, Continuous
Seed Study
37.7 years37.7 years
Race (NIH/OMB)
Pita Study
American Indian or Alaska Native
0 Participants0 Participants
Race (NIH/OMB)
Pita Study
Asian
11 Participants11 Participants
Race (NIH/OMB)
Pita Study
Black or African American
1 Participants1 Participants
Race (NIH/OMB)
Pita Study
More than one race
3 Participants3 Participants
Race (NIH/OMB)
Pita Study
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants
Race (NIH/OMB)
Pita Study
Unknown or Not Reported
3 Participants3 Participants
Race (NIH/OMB)
Pita Study
White
20 Participants20 Participants
Race (NIH/OMB)
Seed Study
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Seed Study
Asian
9 Participants0 Participants9 Participants
Race (NIH/OMB)
Seed Study
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Seed Study
More than one race
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Seed Study
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Seed Study
Unknown or Not Reported
3 Participants0 Participants3 Participants
Race (NIH/OMB)
Seed Study
White
24 Participants0 Participants24 Participants
Region of Enrollment
Canada
38 Participants0 Participants38 Participants
Sex: Female, Male
Pita Study
Female
0 Participants11 Participants11 Participants
Sex: Female, Male
Pita Study
Male
0 Participants27 Participants27 Participants
Sex: Female, Male
Seed Study
Female
10 Participants0 Participants10 Participants
Sex: Female, Male
Seed Study
Male
28 Participants0 Participants28 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 380 / 38
other
Total, other adverse events
0 / 380 / 38
serious
Total, serious adverse events
0 / 380 / 38

Outcome results

Primary

Total Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)

Appetite assessment was measured using a VAS questionnaire administered pre-snack and every 30 minutes post snack up to 180 minutes, for a total of 7 time points. The questionnaire included 4 questions (1) How hungry are you? (2) How full are you? (3) How strong is your desire to eat? (4) How much do you think you want to eat right now? Each question was followed by a 10 cm line anchored at the left and right ends by the opposing statements not at all and extremely for questions 1 and 2, very weak and very strong for question 3, and nothing at all and a very large amount for question 4. Participants provided their response to each question by marking a perpendicular line on the 10-cm line to indicate their answer. Scores were determined by measuring the distance in centimeters from the left anchor to the perpendicular line drawn by the participant. VAS scores over time were graphed and AUC was calculated using the trapezoid method.

Time frame: VAS administered pre-snack and then every 30 minutes after the first bite up to 180 minutes for a total of 7 time points.

Population: A total of 46 participants were enrolled in the Seed and the Pita Study. Of these 46, 30 participated in both studies and 16 enrolled in just one study. 38 participants enrolled in the Seed Study and 38 in the Pita Study.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Experimental Snack #1 Fullness1008 cm x minStandard Error 46
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Experimental Snack #1 Hunger651 cm x minStandard Error 46
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Experimental Snack #1 Desire638 cm x minStandard Error 46
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Experimental Snack #1 Consume640 cm x minStandard Error 42
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Comparator #1 Hunger636 cm x minStandard Error 46
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Comparator #1 Fullness1024 cm x minStandard Error 46
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Comparator #1 Desire659 cm x minStandard Error 46
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Comparator #1 Consume649 cm x minStandard Error 42
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Comparator #1 Non-caloric Control Hunger962 cm x minStandard Error 46
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Control #1 Non-caloric Control Fullness682 cm x minStandard Error 47
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Control #1 Non-caloric Control Desire980 cm x minStandard Error 47
Seed StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Seed Study Placebo Comparator Non-caloric Control #1 Consume916 cm x minStandard Error 42
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Experimental Snack #2 Hunger611 cm x minStandard Error 40
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Experimental Snack #2 Fullness1005 cm x minStandard Error 41
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Experimental Snack #2 Desire616 cm x minStandard Error 44
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Experimental Snack #2 Consume599 cm x minStandard Error 38
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Reference Product Hunger661 cm x minStandard Error 39
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Reference Product Fullness968 cm x minStandard Error 40
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Reference Product Desire682 cm x minStandard Error 43
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Reference Product Consume676 cm x minStandard Error 38
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Non-caloric Control Hunger956 cm x minStandard Error 39
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Non-caloric Control Fullness675 cm x minStandard Error 40
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Non-caloric Control Desire1001 cm x minStandard Error 43
Pita StudyTotal Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS)Pita Study Placebo Comparator #2 Non-caloric Control Consume959 cm x minStandard Error 38
Comparison: Items #1 were compared to each other and Items #2 were compared to each otherp-value: <0.05ANCOVA
Secondary

Number of Calories Consumed Post-snack Until Bedtime

Participants were provided with a food diary to record the amount and type of each food and beverage consumed for the remainder of the day. Energy consumed at lunch and the remainder of the day were quantified from food consumed at lunch and the food diary using Food Processor Nutrient Analysis Software.

Time frame: time between snack consumption and bedtime (12 hours)

Population: In the Seed Study data for 36 participants was analyzed. One participant was not analyzed due to non compliance and a second participant for not providing a food record. In the Pita Study data from 34 participants was analyzed. One participant was noncompliant and 3 did not turn in food records.

ArmMeasureGroupValue (MEAN)Dispersion
Seed StudyNumber of Calories Consumed Post-snack Until BedtimeSeed Study Experimental Snack #11429 kcalStandard Error 70
Seed StudyNumber of Calories Consumed Post-snack Until BedtimeSeed Study Placebo Comparator #1 Reference Product1326 kcalStandard Error 94
Seed StudyNumber of Calories Consumed Post-snack Until BedtimeSeed Study Placebo Comparator #1 Non-caloric Control1288 kcalStandard Error 80
Pita StudyNumber of Calories Consumed Post-snack Until BedtimePita Study Experimental Snack #21448 kcalStandard Error 89
Pita StudyNumber of Calories Consumed Post-snack Until BedtimePita Study Placebo Comparator #2 Reference Product1414 kcalStandard Error 78
Pita StudyNumber of Calories Consumed Post-snack Until BedtimePita Study Placebo Comparator #2 Non-caloric Control1478 kcalStandard Error 75
Comparison: Items #1 were compared to each other and Items #2 were compared to each otherp-value: <0.05ANCOVA
Other Pre-specified

Gastrointestinal Side Effects

Participants were asked if they noticed any gastrointestinal side effects after having eaten the study food and the results were recorded.

Time frame: 24h

Other Pre-specified

Likeability of Test and Reference Products Based on Sensory Scales

Likability of the study products was assessed using a 5-point hedonic scale (1 = dislike extremely; 2 = dislike very moderately; 3 = neither like or dislike; 4 = like moderately; 5 = like extremely) for appearance, aroma, flavour, taste, texture and overall liking.

Time frame: immediately after eating test or reference product

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack taste3.57 sensory rating on a scale of 1 to 5Standard Error 0.2
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack texture3.66 sensory rating on a scale of 1 to 5Standard Error 0.19
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack appearance3.57 sensory rating on a scale of 1 to 5Standard Error 0.16
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack overall3.48 sensory rating on a scale of 1 to 5Standard Error 0.18
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack aroma3.4 sensory rating on a scale of 1 to 5Standard Error 0.11
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference taste3.23 sensory rating on a scale of 1 to 5Standard Error 0.2
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference texture2.64 sensory rating on a scale of 1 to 5Standard Error 0.19
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference appearance3.49 sensory rating on a scale of 1 to 5Standard Error 0.16
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference aroma3.34 sensory rating on a scale of 1 to 5Standard Error 0.11
Seed StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference overall3.05 sensory rating on a scale of 1 to 5Standard Error 0.18
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference appearance3.74 sensory rating on a scale of 1 to 5Standard Error 0.14
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack taste3.66 sensory rating on a scale of 1 to 5Standard Error 0.15
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference taste3.67 sensory rating on a scale of 1 to 5Standard Error 0.15
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack texture3.49 sensory rating on a scale of 1 to 5Standard Error 0.19
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference overall3.58 sensory rating on a scale of 1 to 5Standard Error 0.14
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack appearance3.81 sensory rating on a scale of 1 to 5Standard Error 0.14
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference texture3.36 sensory rating on a scale of 1 to 5Standard Error 0.19
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack overall3.64 sensory rating on a scale of 1 to 5Standard Error 0.15
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesPlacebo Comparator Reference aroma3.39 sensory rating on a scale of 1 to 5Standard Error 0.1
Pita StudyLikeability of Test and Reference Products Based on Sensory ScalesExperimental Snack aroma3.45 sensory rating on a scale of 1 to 5Standard Error 0.1
Comparison: Items #1 were compared to each other and Items #2 were compared to each otherp-value: <0.05ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026